Experts Matter. Find Yours.
Connect for media, speaking, professional opportunities & more.
As data breaches soar, how will security evolve?
Awareness of data breaches is growing but not nearly at the pace of the problem itself. Indeed, the total number of data compromises jumped 68% in 2021 to an all-time high, impacting more than 293 million people, according to the Identity Theft Resource Center. Also, as more people work from home and embrace Internet of Things devices, individuals can be as vulnerable to hacks and phishing as big corporations and governments, perhaps more so, given that the top three breached data attributes in 2021 were name, social security number and date of birth, the center reported. Bringing a multifaceted perspective to data security challenges is NJIT’s Kurt Rohloff, an academic researcher and entrepreneur who conducts research for the federal government. Rohloff, director of NJIT’s Cybersecurity Research Center, is co-founder and chief technology officer of Duality Technologies, a startup offering data security through homomorphic encryption. His government work includes projects for the Defense Advanced Research Projects Agency of the U.S. Department of Defense and the National Security Agency. Questions that Rohloff can answer include: How has data security evolved? Which tactics fail and why? What’s the economic impact of data breaches? What’s the future of data security? To reach Kurt, simply click on the button below.
Does medical marijuana work? Florida consortium seeks answers
By Emma Richards A consortium of nine universities in Florida, led by faculty at the University of Florida, is in the early stages of investigating the effectiveness of marijuana as a medical treatment. Almut Winterstein, a professor at the University of Florida who also serves as the director of the Consortium for Medical Marijuana Outcomes Research, says there is promising data on pain therapy and epilepsy but much still to learn about cannabis as a medical treatment. The Consortium for Medical Marijuana Outcomes Research is assessing the drug’s risks and benefits for different medical conditions and its safety and side effects when used alone or in conjunction with other prescription medications. “What I can tell you is that right now there is promising and fairly solid data that supports the use of medical marijuana as an adjuvant for pain therapy,” said Almut Winterstein, a professor in the College of Pharmacy at UF who also serves as the director of the consortium. “And there’s also evidence that supports the use for certain types of epilepsy.” As for other conditions, the impacts of medical marijuana are still unknown. The Florida State Legislature created the consortium in 2019, four years after enacting legislation that permits use of marijuana for certain clinical conditions. Currently, 37 states have a medical marijuana program, though the programs vary as far as how and to whom cannabis can be prescribed. But, Winterstein said, little is known about marijuana’s clinical safety and effectiveness. “I think that the Legislature was really forward looking in creating something that supplements the research that is currently not sufficient,” she said in an episode of the From Florida Podcast. The consortium will also gauge who is using and able to access medical marijuana and determine the benefits and drawbacks of different dosages. To do so, the group is working on three primary branches of research. The first area is a competitive grants program that funds researchers across all participating universities. The second branch is M3, or Medical Marijuana and Me, a new study that will track patients from their first use of medical marijuana for a year to assess their experiences. “That will give us ideas about what type of dosage, form and product do patients eventually end up on,” Winterstein said. “That is a very empirical approach because we have no head-to-head comparison of what works better or worse, but we can capture patients’ experiences, what they think works, what doesn't, what kind of side effects they might experience and so on.” Finally, what Winterstein calls the consortium’s “biggest baby and most important baby” is the Medical Marijuana Outcomes Research Repository, known as MEMORY. The repository will allow researchers to use de-identified dispensing data from the Department of Health to monitor health outcomes of the large population of 700,000 registered medical marijuana patients. These data will give researchers insight on cannabis safety and effects, whether positive or negative, linking to healthcare utilization, such as hospitalization or emergency department visits. The consortium is hosting the second annual Cannabis Clinical Outcomes Research Conference May, 19-20 in Orlando, where researchers will discuss the latest research on medical marijuana. “We are really trying to get people interested in this topic,” Winterstein said. “And in particular making sure that they have access to objective information that really allows them to make the right decision with respect to the use of medical marijuana.” To hear more about the consortium’s medical marijuana research, listen to the episode on From Florida at this link. Listen to other episodes in the From Florida podcast here. Read a recent article quoting Professor Winterstein here:
INNOVATORS BRING AI INTO IMAGING SKILLS DEVELOPMENT
Originally from CHT Magazine By Jerry Zeidenberg October 30, 2019 Two Ontario hospital organizations – encompassing six sites – will soon deploy artificial intelligence to help with continuous learning and peer review in their imaging departments. By automatically detecting the types of cases being read by radiologists at St. Joseph’s Healthcare Hamilton and Hamilton Health Sciences, the system will deliver the latest journal findings, as well as personal pattern recognition and error avoidance, direct to their desktops. While radiologists at all Canadian hospitals are experts in their field, with years of education and experience, our understanding of diseases and illnesses is rapidly expanding and new insights are constantly appearing. To ensure that they’re aware of the latest research and best practices, many radiologists conduct journal and web searches while they’re reading cases at the hospital, or at night, from home. “Our radiologists and physicians spend a lot of time reading and searching for literature,” said Shairoz Kherani, who until recently was Director of Diagnostic Services at HHS. (She has since moved to Halton Health Care, in nearby Oakville, Ont., where she is Director of Diagnostic Services and Laboratory.) “Finding the right information can be a daunting process. Now it will be readily available.” “There are hundreds of new findings every day,” said Ian Maynard, CEO of RealTime Medical, of Mississauga, Ont., the company that’s providing the AI-powered solution, called AICloudQA™. “Radiologists can spend two or more hours a day searching independent medical data sources,” said Maynard. “Our solution saves radiologists a significant amount of time and effort by searching multiple data sources simultaneously, relative to the case at hand. We’re like a Google search on steroids for relevant medical data, helping radiologists apply the latest findings to their patient care”. Indeed, RealTime Medical is collaborating with Google Cloud and Sightline Innovation to deliver its AI-fueled solutions. The project is also supported by the National Research Council of Canada’s Industrial Research Assistance Program (NRC IRAP), resulting in a collaboration between these organizations and the hospitals using the solution. Not only does the automated searching save time and contribute to better medical outcomes for patients, but it helps reduce radiologist “burnout”, a serious issue today as radiologists feel overloaded by the demands placed on them, Maynard said. St. Joseph’s Healthcare Hamilton and Hamilton Health Sciences will introduce AICloudQA for peer learning and skills development across their sites by the end of this year. The hospitals will probably start with one site, or one physician group across all sites, and then steadily roll out the solution. The context-sensitive provision of journal articles and other sources of medical information is expected to be of great help to the radiologists, nuclear medicine physicians, cardiologists and other clinicians who use the system. There are 70 to 80 radiologists and medical imaging experts at Hamilton Health Sciences and St. Joseph’s Healthcare Hamilton who will be the prime users of AICloudQA. RealTime Medical’s Ian Maynard said the importance of timely and accurate information cannot be underestimated. As they’re reading cases, radiologists want the latest literature and personal pattern recognition notifications of what to be on the lookout for. “What they don’t want our patients and their families coming back to them later, asking why they didn’t know about the latest finding from Cleveland Clinic for example,” said Maynard. Dr. Karen Finlay, radiologist and Interim Chief of Radiology at Hamilton Health Sciences, agreed that radiologists are currently taking “a lot of time for research”. “If a radiologist steps off a case for five to 10 minutes to go to Google Scholar, that can really add up over the course of a day,” she said. Additionally, for those familiar with the impact of interruptions on the efficiency of the diagnostic process, that time impact can be significantly magnified to the detriment of diagnostic efficiency, which collectively impacts system-wide efficiency. The feed from AICloudQA, by contrast, is instantaneous, meaning the radiologist doesn’t have to stop what they are doing. Notably, the RealTime Medical system also uses AI to scan the readings done by radiologists, and to provide feedback on areas where they might want to focus on or look more closely in future. “It’s like the blind-spot warning system in your car, only it’s anonymously helping you avoid possible gaps in your own reading patterns,” said Maynard. “This is very valuable,” said Kherani. “The system can do intelligent sampling and note where a radiologist may want to improve. It can even spot patterns, time of day and other conditions when they may be more vulnerable.” Dr. Finlay observed that AICloudQA will also transform the process of peer learning at Hamilton Health Sciences and St. Joseph’s Healthcare Hamilton. It will do this, in one way, by increasing the pool of radiologists participating. One of the limitations of current peer review methods is that there’s often a limited number of potential reviewers, especially when a sub-specialty is involved – such as breast or neuro-imaging. RealTime Medical’s cloud-based solution offers the potential to connect with other hospitals across the province and the country, creating a critical mass of peers with a cross-section of experiences in each sub-speciality. This will enable a level of peer learning and best practice sharing that’s simply not possible with site-based systems. Increasing the number of radiologists in the peer learning pool also helps with the issue of anonymity. With site-based solutions, it’s sometimes possible to guess the identity of the radiologist or clinician being assisted, as physicians are often familiar with the reporting styles of their peers. Like all physicians – and people in general – radiologists don’t like to be judged. By making the system more anonymous, the Real Time Medical system makes peer learning more objective, valid and hence palatable for participants. This part of what is being called a “just culture” approach, that physicians are calling for in such solutions. AICloudQA embraces the “just culture” principles that physicians want and deserve. It is not punitive, and the information is not shared. Instead, it’s sent privately to the participating radiologist or clinicians, who can use it for self-improvement. At Hamilton Health Sciences and St. Joseph’s Healthcare Hamilton, the peer-reviewing will be prospective – that is, it’s done before the results are reported to the referring physician. Of course, there are only so many cases that can be reviewed before the process becomes counter-productive. The need for continuous learning must be balanced with the extra burden that’s placed on reviewers. “The trick is to make it a rich and rewarding learning experience, but not burdensome,” said Dr. Finlay. Hamilton Health Sciences and St. Joseph’s Healthcare Hamilton currently aim to review 2 percent of the cases, which is in keeping with other Canadian programs. Kherani noted there are other potential benefits to the AICloudQA platform. It has a workload balancing function, where it uses its intelligence to feed cases to the appropriate radiologist – based on availability and expertise. That not only offers the organization advantages with workflow and wait times, but it also benefits patients, as they obtain the most expert radiologist available. She said the system can eventually support different types of physicians involved in imaging, such as cardiologists, and not only radiologists. “It’s a multi-ology solution.” Dr. Finlay noted the system also supports critical results reporting – so that urgent findings are quickly sent to referring doctors. It can also be tweaked to include notification of unexpected findings – flagging colleagues about problems that were unanticipated, but should be addressed.
Van Gogh is coming to Augusta. Are you ready to immerse yourself in 300 of the artist's works?
Beyond Van Gogh — The Immersive Experience is coming to Augusta later this month. The exhibit has been getting rave reviews and has wowed more than 5 million art lovers interested in the famous Dutch painter since it began touring in 2017. It has been named 2021's best immersive experience by USA Today and was ranked among the 12 best immersive experiences in the world by CNN. But before it arrives, hear from Scott Thorp, chair of the Augusta University Pamplin College of Arts, Humanities and Social Sciences Department of Art and Design, for an expert's perspective before the exhibit opens locally. Why do you think an exhibit like this has exceeded expectations nationwide for those who've come to see it? I believe these types of exhibitions exceed expectations because they are so stimulating. They include a new type of interactive media that entirely surrounds the viewer. You are more of a participant than a viewer in these situations. It’s like Disney is coming to your hometown. People are used to craning their necks to view static art on a wall. With this, you have to keep looking around to ensure you are getting everything. The technology here is relatively novel. Plus, it’s all around you. Sometimes museums feel intimidating, stuffy, or exclusive, so not everyone feels comfortable in those environments. However, blockbuster shows for Van Gogh or Monet have historically done exceptionally well. I look back to an exhibition at the Corcoran Gallery of Art in 2003 as a precursor to exhibits that use the work of established artists to create new and interesting environments. A sculptor named Seward Johnson exhibited his sculptural interpretations of impressionist paintings at the Corcoran Gallery of Art. It was called “Beyond the Frame.” And it was a huge success. You could walk into Van Gogh’s bedroom or Renoir’s “Luncheon of the Boating Party.” Do you think we'll see more exhibits like this in the future with other artists? Yes, this is only the beginning. There are several companies like Meow Wolf that do this all the time. Meow Wolf started back in 2008 and has been creating all kinds of engaging, high-tech installations. This will spread to more permanent venues such as the Illuminarium in Atlanta. The Illuminarium currently has a Georgia O’Keefe exhibition up. Could you see permanent exhibits like this in museums to give visitors a unique experience? I actually see these popping up all over the place. As they move forward, I’m sure artists will use this medium as their own. So it won’t be just about an artist of the past; the experience will be the actual work of contemporary artists. One thing that’s also interesting is there are applications for interactive spaces in many fields. Augusta University has an interactive wall in radiology. Thorp is also associate vice president for research at Augusta University and has worked for more than a decade as an exhibiting artist. His research interests include user-centered design, design thinking, and the psychology of creativity. Scott is available to speak about Beyond Van Gogh — The Immersive Experience. Simply click on his icon now to arrange an interview today.
Aston University offers emergency interpreter training for Ukrainian speakers to support refugees
Dr Emmanuelle Labeau and Dr Yvonne Fowler are running Emergency Interpreting Training for Ukrainian Speakers to introduce them to the basics of interpreting The 10-hour training (10 x one hour) will take place on Tuesday and Thursday evenings online for five weeks It is part of an Arts and Humanities Research Council (AHRC) project with support from Aston University’s College of Business and Social Sciences. Aston University has kicked off a five-week introduction to interpreting course for Ukrainian speakers to enable emergency interpreters to support Ukrainian refugees arriving in the UK. It is part of an Arts and Humanities Research Council (AHRC) project called BRUM (Birmingham Research for Upholding Multilingualism) with support from Aston University’s College of Business and Social Sciences. Dr Emmanuelle Labeau (AHRC fellow for the Future of Language Research) and Dr Yvonne Fowler are running Emergency Interpreting Training for Ukrainian Speakers. The 10-hour training scheme (10 one-hour sessions) started on 28 April 2022 and will take place every Tuesday and Thursday evening online for five weeks. It has been devised to enable emergency interpreters to deliver a better service to traumatised Ukrainian refugees whose English is limited and who may require interpreting help in every aspect of their lives to access housing, physical and mental healthcare, educational facilities and welfare benefits. Dr Emmanuelle Labeau, co-director of Aston Centre for Applied Linguistics (ACAL) at Aston University, said: “Ukrainian refugees are arriving in the UK and there are few trained qualified Ukrainian interpreters to support those refugees with limited or no English in their dealings with public services. “We have had a fantastic response to our offer of free emergency training in interpreting for Ukrainian speakers in the West Midlands, as part of the AHRC-funded BRUM project. “I am thrilled that we have been able to pull this together and I am really pleased with how the first session went. We have people of all walks of life such as social services, healthcare, education and even a refugee who are so committed to help in any way they can, and it is lovely to empower them to do so!” Dr Yvonne Fowler said: “I am really proud to see this project get off the ground and help people in need. “I have been a public service interpreter trainer for the last 25 years. “My work has mostly involved preparing interpreters for the Diploma In Public Service, Interpreting Law and Healthcare options. “But during this period, I delivered emergency interpreter training to support various waves of refugees who have come to Birmingham over the last 20 years: the Vietnamese boat refugees, the Bosnian refugees in the aftermath of the Bosnian war, and a month in Kosovo after the war there to train Albanian and Serbian interpreters at the Organisation for Security and Cooperation in Europe.”
Livestreamed public lecture: How to help children develop healthier eating habits
Aston Institute of Health and Neurodevelopment to host second in a series of livestreamed public lectures Molecules to Minds will explore Professor Jackie Blissett’s research into understanding and supporting children’s healthy eating behaviour The one-hour livestream will be followed by a Q&A and round table discussion Aston Institute of Health and Neurodevelopment (IHN) will host its second livestreamed public lecture in the series Molecules to Minds on Aston University’s digital channel Aston Originals on Thursday 5 May 2022. Professor Jackie Blissett, the Institute’s co-director, will present her lecture: Understanding and supporting children's healthy eating behaviour. Jackie will discuss how ‘one size does not fit all’ when it comes to supporting children to develop healthier eating habits. Jackie and her team from the Aston University Psychology of Eating in Adults and Children (PEACh) group will explore how we can better understand and support children's healthy eating habits. The lecture will draw on the latest research undertaken by Jackie as part of the PEACh group. After the one-hour livestreamed lecture, Professor Blissett and members of the Aston University PEACh team, Dr Abigail Pickard and Dr Megan Jarman, will host a Q&A and round table discussion, where audience members can address researchers with their questions. Professor Blissett, co-director of IHN, said: “Why children eat what they eat, and why it is so difficult to change, is much more complicated than many people assume. Our goal is to better understand the complex factors which predict children’s eating so we can design interventions that are more likely to work.” With more than 20 years of experience working in this field, much of Jackie's research has focused on biological, affective and cognitive factors affecting eating and feeding in parents and their children. Jackie’s main interests are in children’s fussy eating, including fruit and vegetable acceptance, emotional eating and obesity. The livestream will take place at 16:00 – 17:00 BST on Thursday 5 May on the Aston Originals YouTube channel. To register for this event please visit our Eventbrite page. For more information about Aston Institute of Health and Neurodevelopment (IHN) please visit our website.
Findings point to potential new therapeutic targets for this highly aggressive, drug-resistant breast cancer subtype In breakthrough research at ChristianaCare’s Helen F. Graham Cancer Center & Research Institute, scientists have discovered that a protein secreted by tumor cells can switch off the body’s natural defenses against triple negative breast cancer (TNBC). The study, led by Jennifer Sims-Mourtada, Ph.D., lead research scientist at the Cawley Center for Translational Cancer Research (CTCR), at the Graham Cancer Center, is reported in The Journal of Translational Medicine, available online. “What we found is that TNBC tumor cells can effectively shut down the body’s defense systems against the tumor by secreting a type of protein called IL-10,” Dr. Sims-Mourtada said. “The presence of this immune system protein forces the antibodies that would normally be created to attack the tumor to become non-reactive and not do what they are supposed to do.” The study was initiated in partnership with The Wistar Institute of Philadelphia, Pennsylvania, in collaboration with the late Raj “Shyam” Somasundaram, Ph.D., a cell biologist at the Melanoma Research Center. “Dr. Sims-Mourtada and her team have brought us tantalizingly close to understanding what drives the aggressive nature of triple negative breast cancer, a treatment-starved disease that disproportionately affects Delaware women,” said Nicholas J. Petrelli, M.D., Bank of America endowed medical director of the Helen F. Graham Cancer Center & Research Institute. “Their work underscores our belief that scientific collaborations such as this one between our Cawley CTCR clinicians and Wistar scientists can smooth the way for new findings to become effective therapies, especially for hard-to-treat and aggressive forms of cancer like TNBC.” Understanding the mechanism behind TNBC Delaware ranks highest in the nation for incidence of triple negative breast cancer. TNBC is an aggressive form that affects Black women at twice the rate of white women with poorer outcomes. Patients have higher rates of early recurrence than other breast cancer subtypes, particularly in the first five years after diagnosis. Currently there is no targeted therapy for TNBC. “One of our missions within the Cawley CTCR is to understand the mechanisms behind TNBC and find a treatment for it,” Dr. Sims-Mourtada said. “Our study sheds new light on what is prompting the body’s immune response to the cancer cells and offers clues to potential new therapeutic targets.” Normally it is the job of the B cells to regulate the immune response against foreign invaders like cancer. Among other jobs, they control inflammation at the site of an attack by releasing proteins including IL-10 to signal the defender cells to stand down. “Previously it was thought that the immune cells were the ones to express IL-10 to regulate themselves,” Dr. Sims-Mourtada said. “But our study shows that the tumor cells also release this protein, which means they are driving how the immune system behaves.” Within the tumor microenvironment, IgG4 is one of four antibody subclasses expressed and secreted by B cells. Whereas another type of antibody would urge the immune system to press on with the attack, activation of IgG4 signals the job is done. TNBC and activation of IgG4 “Our findings support that TNBC may create a tumor environment that supports activation of IgG4, and messaging from IL10 is triggering the switch,” Dr. Sims-Mourtada said. As previously reported with other cancers, such as melanoma, this study confirms that the presence of IgG4-positive B cells within the tumor associates with advanced disease increased recurrence and poor overall breast cancer survival. It is also possible that IL-10 expression by tumor cells may also be a cause of poor outcomes in TNBC, and this may be independent of IgG4+ B cells. “At this point, we don’t know what causes tumor cells to start secreting IL-10, but we know that B cell-tumor cell interactions are involved,” Dr. Sims-Mourtada said. “We still have to look at what is really going on in the B cell population to determine which subtypes of B cells are affected by this tumor crosstalk and why some forms of TNBC express IL-10 (the ones with poor outcomes) and others do not. “We think that the presence or absence of other immune cells in the microenvironment may affect how B cells interact with tumor cells to drive IL-10 expression,” she said. Resources for the study, including blood and tissue samples from consenting patients, were obtained through the Graham Cancer Center’s Tissue Procurement program. Interestingly, in a small subset of samples, the researchers found that IL-10 expression was significantly higher in Black patients than non-Hispanic white patients. These findings need to be confirmed in a larger more diverse population with different TNBC subtypes. Understanding tumor-infiltrating B cells “Our growing understanding of the contribution of IgG4+ cells to the immune microenvironment of TNBC and what drives IL-10 expression may reveal ways in which tumor-infiltrating B cells can contribute to tumor growth and provide new targets to increase the immune response to TNBC,” Dr. Sims-Mourtada said. As partners for more than a decade, Graham Cancer Center research clinicians and Wistar scientists collaborate across disciplines to translate cancer research into more effective therapies for patients everywhere. In addition to providing high-quality, viable tissue samples for Wistar research studies, Graham Cancer Center clinicians actively participate in concept development, sharing their unique understanding of the everyday patient experience.
Aston Institute of Health and Neurodevelopment officially launches new £2.8m MRI scanner
A new £2.8 million MRI scanner has been unveiled at Aston University. The showcase took place in Aston Institute of Health and Neurodevelopment on Monday 25 April. The event was attended by Aston University Interim Vice-Chancellor Saskia Loer Hansen and other members of the University executive team, together with academic researchers in the University’s College of Health and Life Sciences. After an official ribbon-cutting ceremony hosted by the Institute co-directors Professor Jackie Blissett and Professor Gavin Woodhall, guests were invited to take a tour of the new MRI scanner facilities where imaging researchers were on hand to showcase and discuss their research for which the new MRI scanner is a vital facility. Interim Vice-Chancellor Saskia Loer Hansen said: “I am delighted that Aston Institute of Health and Neurodevelopment is home to this state-of-the-art facility. Having a new MRI scanner on our campus will not only enable our scientists to undertake their neuroimaging research, but will also benefit so many patients in the region who urgently need this facility as part of their medical treatment. “Our new MRI scanner further highlights the world-class research that our scientists are undertaking at Aston University.” The new Siemens MAGNETOM Prisma 3T MRI scanner was installed over a period of four months starting in November 2021, including the work undertaken to remove the old machine from the building. The scanner has been made ‘child friendly’ with suitable images and the room which hosts the scanner has a wall mural of cherry blossom trees. The new MRI scanner will enhance the world-class neuroimaging research facilities within the Institute of Health and Neurodevelopment and support the development of the next generation of researchers. Professor Jackie Blissett, co-director of Aston Institute of Health and Neurodevelopment, said: “The new MRI scanner will enhance the world-class neuroimaging research facilities within the Institute of Health and Neurodevelopment. It will allow us to answer the questions that matter to children and young people, their families and the services that support them.” Aston University researchers use advanced neuroimaging techniques to examine brain health in children with neurological diseases and developmental disorders and are developing a research programme focused on children and young people to deliver a new understanding of development, disorder and disease and the interventions that will make a difference. The new scanner will also enable the Institute to provide the most recent innovations in MRI for patients visiting through the clinical service Aston University Imaging. Patients visiting for MRI scans come through private referrals, as well as from local institutions such as the Birmingham Royal Ballet and Aston Villa Football Club.
Aston University experts to co-chair The Spring Servitization Conference 2022
The Conference is dedicated to understanding how organisations can develop and adapt their business models through servitization and advances services The theme is Achieving Net-Zero through Servitization and it will be held in Florence, Italy on 9 and 10 May Professor Tim Baines and Dr Ali Z. Bigdeli, from the Advanced Services Group at Aston University, will be co-chairs. Two Aston University experts are set to co-chair a major conference around servitization in Italy in May. Professor Tim Baines and Dr Ali Z. Bigdeli, from the Advanced Services Group (ASG) at Aston University, will be co-chairs alongside Professor Mario Rapaccini (University of Florence), Professor Nicola Saccani and Dr Federico Adrodegari (both University of Brescia) while Jill Forrest (also ASG) will be conference administrator. The Spring Servitization Conference (SSC) was first launched more than 10 years ago at Aston University in Birmingham. It was created to build and formalise a research community around the topic of servitization, and to understand how organisations can develop and adapt their business models through servitization and advances services. Servitization is a term used to describe the process through which a business transitions from selling products alone to selling a combination of product and service, and ultimately outcomes. The theme of the 2022 edition of the conference will be Achieving Net-Zero through Servitization and will be held at Istituto degli Innocenti in Florence on Monday 9 and Tuesday 10 May. The event will bring together the world’s leading researchers, practitioners and doctoral students to debate and engage with the theory and practice of servitization. Professor Tim Baines, executive director of The Advanced Services Group at Aston University and co-chair The Spring Servitization Conference 2022, said: “Servitization has already helped to transform the fortunes of many UK manufacturing businesses and I am looking forward to showcasing what it can do for businesses abroad too. “SSC2022 will follow the now established format of a single stream where all contributors have an opportunity to present to the whole conference audience and engage in both structured and semi-structured panel sessions to discuss their work. “The programme is designed to encourage extensive debate and bridge research theory and industrial practice. “We have some fantastic keynote speeches from senior executives at leading manufacturing businesses including Tim Foreman, European R&D manager, OMRON Europe and Paolo Mauri, Electrolux Professional.” You can find out more about The Spring Servitization Conference 2022 here.
The research looked into the means for achieving higher sustainability performance through circular economy adoption The project was led by Professor Prasanta Dey and Professor Pawan Budhwar from Aston Business School Data was gathered from around 100 SMEs from Greece, France, Spain and the UK. New findings from an Aston University-led study have found Small and Medium Sized Enterprises (SMEs) are likely to achieve higher environmental performance through circular economy (CE) adoption. CE is a systemic approach to economic development designed to benefit businesses, society, and the environment. In contrast to the 'take-make-waste' linear model, a circular economy is regenerative by design and aims to gradually decouple growth from the consumption of finite resources. The project was led by Professor Prasanta Dey and Professor Pawan Budhwar from Aston Business School along with Soumyadeb Chowdhury (Toulouse Business School), Krishnendu Saha (Birmingham City University), Debashree De (University of Essex) and Chrysovalantis Malesios (Agricultural University of Athens). Data was gathered from around 100 SMEs from each of the four selected countries – Greece, France, Spain and the UK using a survey to study the current state of CE adoption, and subsequently, focus groups were organised which involved SMEs owners and managers, policymakers, SMEs' customers and suppliers, in each country to derive means for improving sustainability performance. The study reveals that SMEs in all the participating countries are likely to achieve higher environmental performance through CE adoption. SMEs in France were likely to achieve higher overall sustainability performance than other participating countries. It also found products, processes and facilities design is likely to help SMEs most in all the participating countries to adopt CE, while their waste management all needed improvement. Professor Budhwar, head of Aston Business School, said: “Although from prior research there is evidence of SMEs achieving superior environmental performance by adopting CE, economic and social performances are not assured. This motivated us to undertake empirical research to reveal the means for achieving higher sustainability performance (economic, environmental, and social) through CE adoption”. “The findings of this research enable us to continue CE adoption not only in other European countries but also in India, Thailand, Vietnam and Kenya”. Professor Dey, a professor in operations and information management at Aston Business School, said: “SMEs in the EU countries are likely to have sustainable design practices aligned with the CE philosophy. On the contrary, SMEs in the participating countries are likely to have worst recover function. “This implies that customers' pressure works for SMEs to adopt CE principles as design function in most of the SMEs' businesses is governed by SMEs' customers. Whereas effective recover function depends on SMEs' self-motivation and policymakers’ pressure.” “CE adoption needs a structured approach of analysing current state of CE through analysing correlation of organisational value functions with sustainability performance, identifying issues and challenges, and suggesting means for improvement across value functions.” You can read the full report here.
